Free Trial

International Biotechnology (LON:IBT) Shares Pass Above 200-Day Moving Average - What's Next?

International Biotechnology logo with Financial Services background

International Biotechnology (LON:IBT - Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 666.53 ($8.58) and traded as high as GBX 732 ($9.42). International Biotechnology shares last traded at GBX 726 ($9.34), with a volume of 144,508 shares changing hands.

International Biotechnology Stock Down 0.3 %

The firm has a 50 day moving average price of GBX 683.04 and a 200-day moving average price of GBX 666.53. The company has a current ratio of 0.46, a quick ratio of 0.32 and a debt-to-equity ratio of 9.66. The firm has a market cap of £267.59 million, a PE ratio of 1,512.50 and a beta of 0.21.

International Biotechnology Company Profile

(Get Free Report)

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.

Read More

Should you invest $1,000 in International Biotechnology right now?

Before you consider International Biotechnology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.

While International Biotechnology currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines